132 related articles for article (PubMed ID: 8544060)
41. [Infection of the athymic rat by Toxoplasma gondii].
Santoro F; Auriault C; Leite P; Darcy F; Capron A
C R Acad Sci III; 1987; 304(11):297-300. PubMed ID: 3103874
[TBL] [Abstract][Full Text] [Related]
42. Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.
Smiley ST; Lanthier PA; Couper KN; Szaba FM; Boyson JE; Chen W; Johnson LL
J Immunol; 2005 Jun; 174(12):7904-11. PubMed ID: 15944296
[TBL] [Abstract][Full Text] [Related]
43. Importance of gender and sex hormones in regulation of susceptibility of the small intestine to peroral infection with Toxoplasma gondii tissue cysts.
Liesenfeld O; Nguyen TA; Pharke C; Suzuki Y
J Parasitol; 2001 Dec; 87(6):1491-3. PubMed ID: 11780848
[TBL] [Abstract][Full Text] [Related]
44. Lymphocyte subpopulations and function in chronic murine toxoplasmosis.
Macario AJ; Stahl W; Miller R
Clin Exp Immunol; 1980 Sep; 41(3):415-22. PubMed ID: 6969157
[TBL] [Abstract][Full Text] [Related]
45. Impairment of natural resistance to Toxoplasma gondii infection in rats treated with beta adrenergics, beta blockers, corticosteroids or total body irradiation.
Benedetto N; Folgore A; Galdiero M
Pathol Biol (Paris); 1993 Apr; 41(4):404-9. PubMed ID: 8233643
[TBL] [Abstract][Full Text] [Related]
46. Effects of nontoxic lipid A and endotoxin on resistance of mice to Toxoplasma gondii.
Masihi KN; Ribi E; Lange W; Werner H
J Biol Response Mod; 1988 Dec; 7(6):535-9. PubMed ID: 3216221
[TBL] [Abstract][Full Text] [Related]
47. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis.
McLeod R; Beem MO; Estes RG
J Clin Lab Immunol; 1985 Jul; 17(3):149-53. PubMed ID: 3930751
[TBL] [Abstract][Full Text] [Related]
48. Gamma delta T cells and acute primary Toxoplasma gondii infection in mice.
Sayles PC; Rakhmilevich AL; Johnson LL
J Infect Dis; 1995 Jan; 171(1):249-52. PubMed ID: 7798675
[TBL] [Abstract][Full Text] [Related]
49. Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero.
Johnson LL
Infect Immun; 1994 Aug; 62(8):3075-9. PubMed ID: 8039874
[TBL] [Abstract][Full Text] [Related]
50. The effect of zinc supplementation in experimentally induced Toxoplasma gondii infection.
Tasçi S; Sengil AZ; Altindis M; Arisoy K
J Egypt Soc Parasitol; 1995 Dec; 25(3):745-51. PubMed ID: 8586868
[TBL] [Abstract][Full Text] [Related]
51. Temporary restoration of immune response against Toxoplasma gondii in HIV-infected individuals after HAART, as studied in the hu-PBMC-SCID mouse model.
Alfonzo M; Blanc D; Troadec C; Huerre M; Eliaszewicz M; Gónzalez G; Koyanagi Y; Scott-Algara D
Clin Exp Immunol; 2002 Sep; 129(3):411-9. PubMed ID: 12197881
[TBL] [Abstract][Full Text] [Related]
52. [Analysis of the soluble antigens in the peritoneal exudate of mice infected with Toxoplasma gondii].
Yang XZ; Yang SS; Wu ZQ; Yu AD
Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(1):36-8. PubMed ID: 6467542
[No Abstract] [Full Text] [Related]
53. Immunity to Toxoplasma gondii.
Subauste CS; Remington JS
Curr Opin Immunol; 1993 Aug; 5(4):532-7. PubMed ID: 8216929
[TBL] [Abstract][Full Text] [Related]
54. Role of natural killer and NK1+ T-cells in regulating cell-mediated immunity during Toxoplasma gondii infection.
Denkers EY; Sher A
Biochem Soc Trans; 1997 May; 25(2):699-703. PubMed ID: 9191186
[No Abstract] [Full Text] [Related]
55. Experimental Toxoplasma gondii infection in mice: the role of the fifth component of complement.
Araujo FG; Rosenberg LT; Remington JS
Proc Soc Exp Biol Med; 1975 Jul; 149(3):800-4. PubMed ID: 1144466
[TBL] [Abstract][Full Text] [Related]
56. Host resistance and the immune system.
Ben-Yehuda A; Weksler ME
Clin Geriatr Med; 1992 Nov; 8(4):701-11. PubMed ID: 1423129
[TBL] [Abstract][Full Text] [Related]
57. Age-related defense against infection with intracellular pathogens.
Emmerling P; Hof H; Finger H
Gerontology; 1979; 25(6):327-36. PubMed ID: 116909
[TBL] [Abstract][Full Text] [Related]
58. Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production.
Walker W; Roberts CW; Ferguson DJ; Jebbari H; Alexander J
Infect Immun; 1997 Mar; 65(3):1119-21. PubMed ID: 9038327
[TBL] [Abstract][Full Text] [Related]
59. Production and cellular origin of gamma interferon induced by lipopolysaccharide in mice infected with Toxoplasma gondii.
Shirahata T; Tsukada Y; Ohta C; Goto H
Nihon Juigaku Zasshi; 1990 Dec; 52(6):1325-8. PubMed ID: 2126828
[No Abstract] [Full Text] [Related]
60. [Acute nonspecific inflammatory reaction and modification of resistance to Toxoplasma gondii].
Dumas N; Seguela JP; Giroud JP
Bull Soc Pathol Exot Filiales; 1984; 77(2):190-5. PubMed ID: 6722969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
